SCHEMBL6364379

SCHEMBL6364379

CCOC(=O)Nc1ccc2c(c1)CCNC(=O)N2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.46
LMNA P02545 4/20 0.46
MEN1 O00255 4/20 0.46
ALDH1A1 P00352 4/20 0.46
HSD17B10 Q99714 3/20 0.46
TSHR P16473 3/20 0.46
MAPT P10636 2/20 0.46
ALOX15 P16050 2/20 0.46
GAA P10253 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
NOX1 Q9Y5S8 1/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
CYP2C9 P11712 2/20 0.46
CYP2C19 P33261 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
HTT P42858 1/20 0.46
KDM4E B2RXH2 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10367113 0.84 HDAC3 (0.57) KMT2ALMNAMEN1ALDH1A1HSD17B10
SCHEMBL9557089 0.73 KMT2A (0.77) KMT2ALMNAMEN1ALDH1A1HSD17B10
SCHEMBL2000310 0.72 BAZ2B (0.55) KMT2ALMNAMEN1ALDH1A1HSD17B10
SCHEMBL7903033 0.71 RAB9A (0.57) KMT2AMEN1ALDH1A1TSHRMAPT
SCHEMBL22160852 0.71 CA12 (0.43) KMT2AMEN1NR1I3
SCHEMBL13525165 0.71 KIF11 (0.45) LMNAALDH1A1HSD17B10GAAKDM4E
SCHEMBL10365651 0.70 CRBN (0.64) KMT2AMEN1HSD17B10ALOX15CYP2C9
SCHEMBL6193791 0.70 BAZ2B (0.63) KMT2AALDH1A1NPC1RAB9ACYP2C9
SCHEMBL2000609 0.70 BAZ2B (0.67) KMT2AALDH1A1MAPTTDP1NPC1
SCHEMBL31426390 0.70 RAB9A (0.51) KMT2ALMNAMEN1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050277630-A1 Antibacterial agents CHUPAK LOUIS S 2005-12-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050277630-A1 Antibacterial agents MRPL21, RPN2, FBL KMT2A 4819/4885LMNA 2919/4885MEN1 2732/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.